Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions

Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions

OBJECTIVES: Our previous study demonstrated that superoxide dismutase levels were higher in tuberculous pleural effusions than in malignant pleural effusions, but that this difference could not be used to discriminate between the tw...

Full description

Bibliographic Details
Main Authors:	Maoshui Wang, Zhiqiang Zhang, Xinfeng Wang
Format:	Article
Language:	English
Published:	Elsevier España 2014-01-01
Series:	Clinics
Subjects:	Superoxide Dismutase 2 Tuberculous Pleural Effusion Malignant Pleural Effusion Biomarker
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014001200799&lng=en&tlng=en

Similar Items

Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
by: Chen KY, et al.
Published: (2016-06-01)

Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion
by: Yan Gu, et al.
Published: (2016-01-01)

A scoring model for diagnosis of tuberculous pleural effusion
by: Senquan Wu, et al.
Published: (2022-09-01)

Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions
by: Abdel-sadek Hamed Al-aarag, et al.
Published: (2019-06-01)

Discrimination of Exudative Pleural Effusions Based on Pleural Adenosine Deaminase (ADA)-C-Reactive Protein (CRP) Levels, and Their Combination: An Observational Prospective Study
by: Garifallia Perlepe, et al.
Published: (2021-08-01)

Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
by: Adel Attia, et al.
Published: (2015-04-01)

Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
by: Renata Báez-Saldaña, et al.

Role of GeneXpert in diagnosing tuberculous pleural effusion compared with thoracoscopic pleural biopsy
by: Mona Mansour Ahmed, et al.
Published: (2020-01-01)

Tuberculose pleural Tuberculous pleural effusions
by: Márcia Seiscento, et al.
Published: (2006-08-01)

Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
by: Omar M. Mohammed, et al.
Published: (2019-07-01)

Malignant pleural mesothelioma with resolution of pleural effusion
by: Sayaka Nishida, et al.
Published: (2023-11-01)

The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions
by: Jinlin Wang, et al.
Published: (2017-12-01)

Role of thoracentesis in the management of tuberculous pleural effusion
by: Mohammed A. Agha, et al.
Published: (2015-01-01)

Diagnostic value of adenosine deaminase in tuberculous and malignant pleural effusion
by: Nariman A. Helmy, et al.
Published: (2012-10-01)

Biomarkers for distinguishing tuberculous pleural effusion from non-tuberculosis effusion: a retrospective study
by: Guo Fei, et al.
Published: (2023-11-01)

A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion
by: Yuanyuan Liu, et al.
Published: (2016-01-01)

Clinical and Epidemiological Features of Tuberculous Pleural Effusion in Alicante, Spain
by: Eusebi Chiner, et al.
Published: (2021-09-01)

Characteristics of pleural effusion with a high adenosine deaminase level: a case–control study
by: Masafumi Shimoda, et al.
Published: (2022-09-01)

Pleural manometry during thoracocentesis in patients with malignant pleural effusion: A randomized controlled trial
by: Aly Sherif Hassaballa, et al.
Published: (2023-01-01)

The Role of PET-CT in the Differential Diagnosis of Malignant-Paramalignant Pleural Effusion
by: Bülent Akkurt, et al.
Published: (2019-12-01)

Role of pleural biopsy in etiological diagnosis of pleural effusion
by: Pandit Sudipta, et al.
Published: (2010-01-01)

Usefulness of fiberoptic pleuroscopy and brushing in patients with unknown pleural effusion
by: Khaled H. Mohamed, et al.
Published: (2013-01-01)

Malignant Pleural Effusions: Updates in Diagnosis and Management
by: Stephen M. Hughes, et al.
Published: (2022-12-01)

Malignant pleural effusion from prostate adenocarcinoma
by: James C. Knight, et al.
Published: (2014-01-01)

Tuberculous pleural effusion occurring concurrently with asbestos-related pleural disease
by: Massa Zantah, MD, et al.
Published: (2017-01-01)

Closed Pleural Biopsy is Still Useful in the Evaluation of Malignant Pleural Effusion
by: Somnath Bhattacharya, et al.
Published: (2012-01-01)

Diagnostic yield and safety of closed needle pleural biopsy in exudative pleural effusion
by: Govind Singh Rajawat, et al.
Published: (2017-07-01)

Methods for Treatment of Malignant Pleural Effusion
by: Alexei L. Charyshkin, et al.
Published: (2020-03-01)

A retrospective study on the combined biomarkers and ratios in serum and pleural fluid to distinguish the multiple types of pleural effusion
by: Liyan Lin, et al.
Published: (2021-03-01)

Approach to malignant pleural effusions: Role of pleural manometry exemplified by case scenarios
by: Irfan Ismail Ayub
Published: (2019-01-01)

Pleural Fluid Resolution Is Associated with Improved Survival in Patients with Malignant Pleural Effusion
by: Christina R. MacRosty, et al.
Published: (2023-05-01)

Malignant pleural effusion biomarkers as predictor for chemical pleurodesis success
by: Sherif Alsayed, et al.
Published: (2015-01-01)

The minimum volume of pleural fluid required to diagnose malignant pleural effusion: A retrospective study
by: Huimin Wu, et al.
Published: (2017-01-01)

Pleural effusion: An unusual cause and association
by: Alam K Navaz, et al.
Published: (2013-01-01)

Diagnostic dilemma in tuberculous pleural effusion
by: Shaban Mohamed Ramadan, et al.
Published: (2017-04-01)

New biomarkers for the diagnosis of pleural effusion
by: Raafat T. El-Sokkary, et al.
Published: (2022-06-01)

Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion
by: Quanlei Bao, et al.
Published: (2020-02-01)

Survival of Patients with Malignant Pleural Effusion: A Single Center Study
by: Mohammad Javad Fallahi, et al.
Published: (1401-04-01)

Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study
by: Hayoung Choi, et al.
Published: (2020-08-01)

Hepatocyte growth factor combined with adenosine deaminase as biomarker for diagnosis of tuberculous pleural effusion
by: Sheng-Cai Zheng, et al.
Published: (2023-07-01)